Featured,Trends & Articles New York Legislators Proposes Bills to Decriminalize Psychedelics By Dennis Mutua May 09, 2022 New York legislators have come up with several bills which are seeking to decriminalize use of psychedelic substances across the state. The bills were introduced late last week. Psychedelics is currently considered a Schedule I co...
Featured,Trends & Articles Canada Financing Research on Psilocybin Treatment for Substance Use Disorder By Dennis Mutua May 06, 2022 The Canadian Institute of Health Research (CIHR), a federal agency will be funding three grant recipients to research on psilocybin treatments for substance use disorder (SUD), depression and end-of-life distress. This grant wi...
Psychedelic Stocks,Shroom News Psychedelic Media Firm Tripsitter.com Integrates its Platform By Dennis Mutua May 05, 2022 Psychedelics media company and educational resource and advocate for responsible use of psychedelics Tripsitter.com has announced a new look for 2022 the relaunch of the platform is already done leaving the website with overhauled...
Psychedelic Stocks,Shroom News Connecticut House Approves Proposal to Grant Certain Patients Access to Psychedelic Treatments By Dennis Mutua May 04, 2022 The Connecticut House of Representatives approved a budget bill which included provisions which grant certain patients access to psychedelics assisted therapies. According to Marijuana Moment, the psychedelics in question include;...
Featured,Spotlight Stock Mycotopia Therapies Partners With PsyvehedelicsEUROPE to Explore Opportunities Across Europe By Dennis Mutua May 03, 2022 Biotechnology company focused on research, development and commercialization of novel therapeutics based on naturally-derived psilocybin Mycotopia Therapies Inc. (OTCMKTS: TPIA) has entered into a partnership with Belgium based pu...
Featured,Spotlight Stock,Trends & Articles Field Trip to Spin Off Into Two Separate Publicly Traded Companies By Dennis Mutua May 02, 2022 Psychedelics company focusing on development and delivery of technology enabled psychedelic therapies Field Trip Health Ltd. (NASDAQ: FTRP) (TSE: FTRP) announced that it will be separating into two divisions which will both be pub...
Featured,Spotlight Stock,Trends & Articles Optimi Health Completes Largest GMP-Grade Licensed Psilocybin Cultivation Facility in Canada By Dennis Mutua April 29, 2022 Psychedelics company engaging in development, cultivation, extraction, processing and distribution of functional mushrooms Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) announced that it will be officially launching its recently ...
Psychedelic Stocks,Shroom News Researchers From UNLV to Conduct Study on Use of Psychedelics Compounds By Dennis Mutua April 28, 2022 Researchers from the University of Nevada, Las Vegas have initiated a study on psychedelics drugs such as LCD, mescaline and psilocybin among others to find out their potential mental health application of these drugs. The abov...